Bio-Rad Laboratories (BIO) Competitors $237.34 -3.09 (-1.29%) As of 12:34 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock BIO vs. MTD, WAT, ILMN, TECH, BRKR, CRL, PACB, HBIO, TMO, and AShould you be buying Bio-Rad Laboratories stock or one of its competitors? The main competitors of Bio-Rad Laboratories include Mettler-Toledo International (MTD), Waters (WAT), Illumina (ILMN), Bio-Techne (TECH), Bruker (BRKR), Charles River Laboratories International (CRL), Pacific Biosciences of California (PACB), Harvard Bioscience (HBIO), Thermo Fisher Scientific (TMO), and Agilent Technologies (A). These companies are all part of the "life sciences tools & services" industry. Bio-Rad Laboratories vs. Mettler-Toledo International Waters Illumina Bio-Techne Bruker Charles River Laboratories International Pacific Biosciences of California Harvard Bioscience Thermo Fisher Scientific Agilent Technologies Bio-Rad Laboratories (NYSE:BIO) and Mettler-Toledo International (NYSE:MTD) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their risk, earnings, valuation, institutional ownership, community ranking, media sentiment, analyst recommendations, dividends and profitability. Is BIO or MTD more profitable? Mettler-Toledo International has a net margin of 22.29% compared to Bio-Rad Laboratories' net margin of -71.86%. Bio-Rad Laboratories' return on equity of 3.90% beat Mettler-Toledo International's return on equity.Company Net Margins Return on Equity Return on Assets Bio-Rad Laboratories-71.86% 3.90% 2.76% Mettler-Toledo International 22.29%-591.54%26.78% Does the media prefer BIO or MTD? In the previous week, Mettler-Toledo International had 14 more articles in the media than Bio-Rad Laboratories. MarketBeat recorded 30 mentions for Mettler-Toledo International and 16 mentions for Bio-Rad Laboratories. Mettler-Toledo International's average media sentiment score of 1.11 beat Bio-Rad Laboratories' score of 1.10 indicating that Mettler-Toledo International is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Bio-Rad Laboratories 7 Very Positive mention(s) 3 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Mettler-Toledo International 14 Very Positive mention(s) 5 Positive mention(s) 7 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Does the MarketBeat Community prefer BIO or MTD? Bio-Rad Laboratories and Mettler-Toledo International both received 372 outperform votes by MarketBeat users. However, 64.58% of users gave Bio-Rad Laboratories an outperform vote while only 56.45% of users gave Mettler-Toledo International an outperform vote. CompanyUnderperformOutperformBio-Rad LaboratoriesOutperform Votes37264.58% Underperform Votes20435.42% Mettler-Toledo InternationalOutperform Votes37256.45% Underperform Votes28743.55% Which has more risk and volatility, BIO or MTD? Bio-Rad Laboratories has a beta of 1.12, suggesting that its stock price is 12% more volatile than the S&P 500. Comparatively, Mettler-Toledo International has a beta of 1.28, suggesting that its stock price is 28% more volatile than the S&P 500. Do analysts rate BIO or MTD? Bio-Rad Laboratories currently has a consensus price target of $380.20, indicating a potential upside of 58.23%. Mettler-Toledo International has a consensus price target of $1,304.25, indicating a potential upside of 23.47%. Given Bio-Rad Laboratories' stronger consensus rating and higher possible upside, equities research analysts clearly believe Bio-Rad Laboratories is more favorable than Mettler-Toledo International.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Bio-Rad Laboratories 0 Sell rating(s) 2 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.60Mettler-Toledo International 1 Sell rating(s) 5 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.22 Do institutionals & insiders have more ownership in BIO or MTD? 65.2% of Bio-Rad Laboratories shares are owned by institutional investors. Comparatively, 95.1% of Mettler-Toledo International shares are owned by institutional investors. 17.1% of Bio-Rad Laboratories shares are owned by insiders. Comparatively, 1.9% of Mettler-Toledo International shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term. Which has better earnings & valuation, BIO or MTD? Mettler-Toledo International has higher revenue and earnings than Bio-Rad Laboratories. Bio-Rad Laboratories is trading at a lower price-to-earnings ratio than Mettler-Toledo International, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBio-Rad Laboratories$2.57B2.62-$1.84B-$65.04-3.69Mettler-Toledo International$3.87B5.69$863.14M$40.5326.06 SummaryMettler-Toledo International beats Bio-Rad Laboratories on 11 of the 16 factors compared between the two stocks. Get Bio-Rad Laboratories News Delivered to You Automatically Sign up to receive the latest news and ratings for BIO and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BIO vs. The Competition Export to ExcelMetricBio-Rad LaboratoriesAnalytical instruments IndustryMedical SectorNYSE ExchangeMarket Cap$6.73B$4.13B$5.54B$18.96BDividend YieldN/A0.57%5.09%4.01%P/E Ratio-3.6926.9722.5832.88Price / Sales2.624.24401.1328.03Price / Cash26.9536.1538.1817.52Price / Book1.021.666.774.47Net Income-$1.84B-$83.57M$3.22B$1.02B7 Day Performance-0.80%-2.36%1.10%0.59%1 Month Performance-1.99%-2.94%2.49%-3.54%1 Year Performance-13.97%-34.57%15.76%3.80% Bio-Rad Laboratories Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BIOBio-Rad Laboratories4.4134 of 5 stars$237.34-1.3%$380.20+60.2%-12.2%$6.65B$2.57B-3.658,200Earnings ReportShort Interest ↑News CoveragePositive NewsGap UpMTDMettler-Toledo International3.7335 of 5 stars$1,061.95+0.0%$1,304.25+22.8%-15.7%$22.13B$3.87B26.2018,000Earnings ReportShort Interest ↑Positive NewsWATWaters3.9939 of 5 stars$340.10+0.7%$392.13+15.3%+8.1%$20.23B$2.96B31.768,200Upcoming EarningsILMNIllumina4.6973 of 5 stars$77.22-0.2%$138.70+79.6%-38.6%$12.22B$4.37B-10.0511,500Upcoming EarningsAnalyst ForecastPositive NewsTECHBio-Techne4.8869 of 5 stars$50.25+0.0%$81.14+61.5%-32.4%$7.94B$1.20B50.763,000Upcoming EarningsPositive NewsGap UpBRKRBruker4.983 of 5 stars$39.66+1.5%$65.00+63.9%-50.2%$6.01B$3.37B52.188,520Upcoming EarningsShort Interest ↓Positive NewsCRLCharles River Laboratories International4.8168 of 5 stars$115.16+0.4%$182.00+58.0%-49.8%$5.66B$4.05B767.7321,400Upcoming EarningsPositive NewsGap UpPACBPacific Biosciences of California3.1647 of 5 stars$1.13+3.7%$2.45+116.8%-34.3%$336.57M$154.01M-0.69730Upcoming EarningsNews CoveragePositive NewsHBIOHarvard Bioscience3.9609 of 5 stars$0.38+1.5%$4.50+1,076.5%-91.1%$16.91M$94.14M-1.16490Upcoming EarningsGap UpTMOThermo Fisher Scientific4.86 of 5 stars$421.55-0.6%$616.95+46.4%-27.0%$159.13B$42.90B25.50130,000Analyst ForecastInsider TradeShort Interest ↑Gap UpAAgilent Technologies4.7336 of 5 stars$106.99+0.7%$143.00+33.7%-23.2%$30.50B$6.51B24.6017,900Positive NewsGap Up Related Companies and Tools Related Companies Mettler-Toledo International Alternatives Waters Alternatives Illumina Alternatives Bio-Techne Alternatives Bruker Alternatives Charles River Laboratories International Alternatives Pacific Biosciences of California Alternatives Harvard Bioscience Alternatives Thermo Fisher Scientific Alternatives Agilent Technologies Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:BIO) was last updated on 5/2/2025 by MarketBeat.com Staff From Our PartnersThe next market Nvidia is positioned to dominate …Robots — built by Nvidia. Forbes says this could be " a $24 trillion opportunity for investors." Huang s...Weiss Ratings | SponsoredElon just did WHAT!?As you may recall, Biden and the Fed were working on a central bank digital currency, or CBDC. Had they got...Brownstone Research | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredIs he more powerful than Trump? Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredBlackrock’s Sending THIS Crypto Higher on PurposeWhile everyone's distracted by Bitcoin's moves, a stealth revolution is underway. One altcoin is quietly po...Crypto 101 Media | SponsoredFeds Just Admitted It—They Can Take Your CashThe Government Just Said Your Money Isn't Yours That's right—According to the DOJ, YOUR hard-earned money i...Priority Gold | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bio-Rad Laboratories, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Bio-Rad Laboratories With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
